• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型流感病毒H1和H2毒株血凝素之间保守的一个共同中和表位。

A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

作者信息

Okuno Y, Isegawa Y, Sasao F, Ueda S

机构信息

Department of Preventive Medicine, Osaka University, Japan.

出版信息

J Virol. 1993 May;67(5):2552-8. doi: 10.1128/JVI.67.5.2552-2558.1993.

DOI:10.1128/JVI.67.5.2552-2558.1993
PMID:7682624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC237575/
Abstract

When mice were immunized with the A/Okuda/57 (H2N2) strain of influenza virus, a unique monoclonal antibody designated C179 was obtained. Although C179 was confirmed to recognize the hemagglutinin (HA) glycoprotein by immunoprecipitation assays, it did not show hemagglutination inhibition activity to any of the strains of the three subtypes of influenza A virus. However, it neutralized all of the H1 and H2 strains but not the H3 strains. Moreover, it inhibited polykaryon formation induced by the H1 and H2 strains but not by the H3 strains. Two antigenic variants against C179 were obtained, and nucleotide sequence analysis revealed that amino acid sequences, from 318 to 322 of HA1 and from 47 to 58 of HA2, conserved among H1 and H2 strains were responsible for the recognition of C179. Since the two sites were located close to each other at the middle of the stem region of the HA molecule, C179 seemed to recognize these sites conformationally. These data indicated that binding of C179 to the stem region of HA inhibits the fusion activity of HA and thus results in virus neutralization and inhibition of cell-cell fusion. This is the first report which describes the presence of conserved antigenic sites on HA not only in a specific subtype but also in two subtypes of influenza A virus.

摘要

当用A/Okuda/57(H2N2)流感病毒株免疫小鼠时,获得了一种独特的单克隆抗体,命名为C179。尽管通过免疫沉淀试验证实C179可识别血凝素(HA)糖蛋白,但它对甲型流感病毒三个亚型的任何毒株均未表现出血凝抑制活性。然而,它能中和所有H1和H2毒株,但不能中和H3毒株。此外,它能抑制由H1和H2毒株诱导的多核体形成,但不能抑制H3毒株诱导的多核体形成。获得了两种针对C179的抗原变异体,核苷酸序列分析表明,HA1的318至322位氨基酸序列以及HA2的47至58位氨基酸序列,在H1和H2毒株中保守,是C179识别的原因。由于这两个位点在HA分子茎区中部彼此靠近,C179似乎以构象方式识别这些位点。这些数据表明,C179与HA茎区的结合抑制了HA的融合活性,从而导致病毒中和以及细胞间融合的抑制。这是第一份描述HA上不仅在特定亚型而且在甲型流感病毒两个亚型中存在保守抗原位点的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b7/237575/534df7cb4dba/jvirol00026-0139-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b7/237575/45f9ffc56e9f/jvirol00026-0138-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b7/237575/534df7cb4dba/jvirol00026-0139-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b7/237575/45f9ffc56e9f/jvirol00026-0138-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b7/237575/534df7cb4dba/jvirol00026-0139-a.jpg

相似文献

1
A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.甲型流感病毒H1和H2毒株血凝素之间保守的一个共同中和表位。
J Virol. 1993 May;67(5):2552-8. doi: 10.1128/JVI.67.5.2552-2558.1993.
2
[A common antigenic epitope in influenza A virus (H1, H2, H5, H6) hemagglutinin].甲型流感病毒(H1、H2、H5、H6)血凝素中的一种共同抗原表位
Vopr Virusol. 1999 May-Jun;44(3):111-5.
3
Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.一种针对甲型流感病毒血凝素抗原位点B的新型单克隆抗体的交叉保护潜力。
PLoS Pathog. 2009 Mar;5(3):e1000350. doi: 10.1371/journal.ppat.1000350. Epub 2009 Mar 20.
4
Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.针对流感病毒血凝素糖多肽HA1和HA2的单克隆抗体。
Acta Virol. 1987 Sep;31(5):374-86.
5
An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus.甲型流感病毒H1、H2、H5和H6亚型血凝素共有的一个表位。
Acta Virol. 1999 Aug;43(4):237-44.
6
HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.甲型H1和H2亚型流感病毒的HA2亚基可诱导产生具有保护性的交叉反应性细胞毒性T淋巴细胞应答。
J Immunol. 1988 Feb 15;140(4):1264-8.
7
Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region.使用针对血凝素(HA)茎区保守表位的单克隆抗体预防和治疗由禽源H5N2甲型流感病毒小鼠适应变种引起的小鼠支气管肺炎
Arch Virol. 2000;145(8):1733-41. doi: 10.1007/s007050070088.
8
Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes.具有包含来自不同亚型表位的嵌合血凝素的甲型流感病毒转染体。
J Virol. 1992 Jan;66(1):399-404. doi: 10.1128/JVI.66.1.399-404.1992.
9
An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.针对流感病毒血凝素表位的单克隆抗体特性分析。
Arch Virol. 1990;114(1-2):1-26. doi: 10.1007/BF01311008.
10
The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region.缺乏球状区域的流感病毒血凝素缺失突变体的免疫活性
J Gen Virol. 1996 Jul;77 ( Pt 7):1483-7. doi: 10.1099/0022-1317-77-7-1483.

引用本文的文献

1
Computationally designed stem-epitope mimetics elicit broadly reactive antibodies.通过计算设计的茎表位模拟物可引发广泛反应性抗体。
bioRxiv. 2025 Jan 22:2025.01.22.634229. doi: 10.1101/2025.01.22.634229.
2
Passive Immunization in the Prevention and Treatment of Viral Infections.被动免疫在病毒感染预防与治疗中的应用
Eur J Immunol. 2025 May;55(5):e202451606. doi: 10.1002/eji.202451606.
3
Targeted Elimination of Influenza Virus and Infected Cells with Near-Infrared Antiviral Photoimmunotherapy (NIR-AVPIT).采用近红外抗病毒光免疫疗法(NIR-AVPIT)靶向清除流感病毒及受感染细胞。

本文引用的文献

1
Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75.香港流感毒株A/爱知/2/68和A/维多利亚/3/75的血凝素之间的抗原漂移。
Nature. 1980 Aug 21;286(5775):771-6. doi: 10.1038/286771a0.
2
Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype.一种人类甲型流感病毒H1亚型血凝素基因的核苷酸序列
Nature. 1981 Jul 2;292(5818):72-5. doi: 10.1038/292072a0.
3
An avian influenza virus of which infectivity is neutralized by antisera lacking hemagglutination-inhibition activity. Brief report.
Pharmaceutics. 2025 Jan 28;17(2):173. doi: 10.3390/pharmaceutics17020173.
4
How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza.广泛中和抗体如何重新定义对流感的免疫力
Antibodies (Basel). 2025 Jan 7;14(1):4. doi: 10.3390/antib14010004.
5
Development of a new genotype-phenotype linked antibody screening system.新型基因型-表型关联抗体筛选系统的开发。
Elife. 2024 Nov 19;13:RP95346. doi: 10.7554/eLife.95346.
6
Soybean extract inhibits influenza virus entry: Mechanistic insights.大豆提取物抑制流感病毒进入:机制洞察
Food Sci Nutr. 2024 Aug 5;12(10):7671-7682. doi: 10.1002/fsn3.4324. eCollection 2024 Oct.
7
Mapping the functional B-cell epitopes of invasion plasmid antigen D (IpaD).鉴定侵袭质粒抗原 D(IpaD)的功能性 B 细胞表位。
Appl Environ Microbiol. 2024 Aug 21;90(8):e0098824. doi: 10.1128/aem.00988-24. Epub 2024 Jul 31.
8
A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain V and an RNA hydrolyzing scFv.一种由HA1特异性中和单域V和RNA水解单链抗体片段组成的抗甲型H1N1/PR8流感病毒的协同疗法。
Front Microbiol. 2024 Apr 19;15:1355599. doi: 10.3389/fmicb.2024.1355599. eCollection 2024.
9
Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease.接种具有抗原复杂性的血凝素混合物可提供广泛的流感疾病保护。
Sci Transl Med. 2024 May;16(745):eadj4685. doi: 10.1126/scitranslmed.adj4685. Epub 2024 May 1.
10
Mosaic quadrivalent influenza vaccine single nanoparticle characterization.马赛克四价流感疫苗单纳米颗粒特性分析。
Sci Rep. 2024 Feb 24;14(1):4534. doi: 10.1038/s41598-024-54876-2.
一种禽流感病毒,其感染性可被缺乏血凝抑制活性的抗血清中和。简报。
Arch Virol. 1982;74(2-3):205-10. doi: 10.1007/BF01314713.
4
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.在病毒介导的膜融合的最适pH值下流感病毒血凝素构象的变化
Proc Natl Acad Sci U S A. 1982 Feb;79(4):968-72. doi: 10.1073/pnas.79.4.968.
5
Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion.从克隆基因表达的流感病毒血凝素可促进膜融合。
Nature. 1982 Dec 16;300(5893):658-9. doi: 10.1038/300658a0.
6
Monoclonal antibodies: a powerful tool for selecting and analyzing mutations in antigens and antibodies.单克隆抗体:用于选择和分析抗原及抗体突变的强大工具。
Annu Rev Microbiol. 1984;38:389-417. doi: 10.1146/annurev.mi.38.100184.002133.
7
Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin.流感病毒血凝素抗原突变体的三维结构
Nature. 1984;311(5987):678-80. doi: 10.1038/311678a0.
8
Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.对应血凝素抗原位点的合成肽对流感病毒的免疫及保护作用
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2461-5. doi: 10.1073/pnas.81.8.2461.
9
Identification of the binding sites to monoclonal antibodies on A/USSR/90/77 (H1N1) hemagglutinin and their involvement in antigenic drift in H1N1 influenza viruses.鉴定A/USSR/90/77(H1N1)血凝素上单克隆抗体的结合位点及其在H1N1流感病毒抗原漂移中的作用。
Virology. 1983 Nov;131(1):116-27. doi: 10.1016/0042-6822(83)90538-x.
10
Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH.H3流感病毒血凝素分子在酸性pH值下的抗原性变化。
Virology. 1983 Apr 30;126(2):587-99. doi: 10.1016/s0042-6822(83)80015-4.